Back to Search
Start Over
1 H-NMR and 13 C-NMR dataset for some oxidative metabolites of CRA13 and their analogs.
- Source :
-
Data in brief [Data Brief] 2018 Oct 10; Vol. 21, pp. 485-500. Date of Electronic Publication: 2018 Oct 10 (Print Publication: 2018). - Publication Year :
- 2018
-
Abstract
- CRA13 (CB-13; SAB-378) is a dual CB <subscript>1</subscript> R/CB <subscript>2</subscript> R agonist cannabinoid agent developed by Novartis Pharma. Upon administration, it undergoes metabolism to oxidative metabolites. Herein, the <superscript>1</superscript> H-NMR and <superscript>13</superscript> C-NMR dataset of some oxidative metabolites and analogs thereof are presented for further analysis and comparison purposes, for whom may be interested.
Details
- Language :
- English
- ISSN :
- 2352-3409
- Volume :
- 21
- Database :
- MEDLINE
- Journal :
- Data in brief
- Publication Type :
- Academic Journal
- Accession number :
- 30364648
- Full Text :
- https://doi.org/10.1016/j.dib.2018.09.069